Morgan Stanley’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-670,371
Closed -$2.55M 6848
2020
Q1
$2.55M Buy
670,371
+130,865
+24% +$497K ﹤0.01% 3135
2019
Q4
$2.75M Buy
539,506
+155,071
+40% +$790K ﹤0.01% 3780
2019
Q3
$1.94M Sell
384,435
-103,301
-21% -$522K ﹤0.01% 3819
2019
Q2
$3.01M Sell
487,736
-43,046
-8% -$266K ﹤0.01% 3425
2019
Q1
$2.46M Buy
530,782
+126,209
+31% +$586K ﹤0.01% 3411
2018
Q4
$1.7M Sell
404,573
-98,776
-20% -$415K ﹤0.01% 3902
2018
Q3
$3.16M Sell
503,349
-432,472
-46% -$2.71M ﹤0.01% 3631
2018
Q2
$7.52M Buy
935,821
+626,043
+202% +$5.03M ﹤0.01% 2699
2018
Q1
$2.31M Buy
309,778
+71,420
+30% +$533K ﹤0.01% 3859
2017
Q4
$1.42M Buy
238,358
+49,215
+26% +$293K ﹤0.01% 4313
2017
Q3
$1.39M Buy
189,143
+70,684
+60% +$520K ﹤0.01% 4196
2017
Q2
$804K Sell
118,459
-155,606
-57% -$1.06M ﹤0.01% 4523
2017
Q1
$2.59M Sell
274,065
-102,821
-27% -$970K ﹤0.01% 3580
2016
Q4
$3.26M Buy
376,886
+309,350
+458% +$2.67M ﹤0.01% 3432
2016
Q3
$428K Buy
67,536
+43,884
+186% +$278K ﹤0.01% 4615
2016
Q2
$100K Buy
23,652
+4,563
+24% +$19.3K ﹤0.01% 5243
2016
Q1
$83K Buy
19,089
+2,559
+15% +$11.1K ﹤0.01% 5405
2015
Q4
$101K Buy
16,530
+609
+4% +$3.72K ﹤0.01% 5399
2015
Q3
$91K Sell
15,921
-47,504
-75% -$272K ﹤0.01% 5463
2015
Q2
$474K Sell
63,425
-374,148
-86% -$2.8M ﹤0.01% 4752
2015
Q1
$2.62M Buy
437,573
+17,866
+4% +$107K ﹤0.01% 3337
2014
Q4
$3.17M Sell
419,707
-395,241
-48% -$2.99M ﹤0.01% 3162
2014
Q3
$4.23M Sell
814,948
-35,456
-4% -$184K ﹤0.01% 2770
2014
Q2
$3.67M Buy
850,404
+87,978
+12% +$379K ﹤0.01% 2958
2014
Q1
$3.12M Buy
762,426
+40,181
+6% +$164K ﹤0.01% 3035
2013
Q4
$3.85M Sell
722,245
-413,353
-36% -$2.2M ﹤0.01% 2811
2013
Q3
$5.7M Buy
1,135,598
+105,022
+10% +$527K ﹤0.01% 2291
2013
Q2
$4.6M Buy
+1,030,576
New +$4.6M ﹤0.01% 2410